STOCK TITAN

Sharecare to report fourth quarter and full year fiscal 2023 financial results on Thursday, March 28

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Sharecare (SHCR) will report Q4 and full year fiscal 2023 financial results on March 28, 2024, after market close. A conference call to review results will be held at 4:30 p.m. EDT on the same day.
Positive
  • None.
Negative
  • None.

ATLANTA, March 27, 2024 (GLOBE NEWSWIRE) -- Sharecare (Nasdaq: SHCR), the digital health company that helps people manage all their health in one place, today announced that it will report fourth quarter and full year fiscal 2023 financial results on Thursday, March 28, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. EDT on the same day.

Conference Call Details
The conference call can be accessed by dialing (833) 636-1352 for U.S. participants, or (412) 902-4148 for international participants, and asking to be joined into the Sharecare call; or via live audio webcast, available online at https://investors.sharecare.com.

A webcast replay of the call will be available for on-demand listening at the same link and will remain available for approximately 90 days.

About Sharecare
Sharecare is the leading digital health company that helps people – no matter where they are in their health journey – unify and manage all their health in one place. Our comprehensive and data-driven virtual health platform is designed to help people, providers, employers, health plans, government organizations, and communities optimize individual and population-wide well-being by driving positive behavior change. Driven by our philosophy that we are all together better, at Sharecare, we are committed to supporting each individual through the lens of their personal health and making high-quality care more accessible and affordable for everyone. To learn more, visit www.sharecare.com.

Important Notice Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 that are based on beliefs and assumptions and on information currently available. In some cases, you can identify forward-looking statements by the following words: “outlook,” “target,” “reflect,” “on track,” “foresees,” “future,” “may,” “deliver,” “will,” “shall,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing” or the negative of these terms, other comparable terminology (although not all forward-looking statements contain these words), or by discussions of strategy, plans, or intentions. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain.

Forward-looking statements in this press release include, but are not limited to, statements regarding the issuance of fourth quarter and full year 2023 financial results.

We cannot assure you that the forward-looking statements in this press release will prove to be accurate. These forward-looking statements are subject to a number of significant risks and uncertainties that could cause actual results to differ materially from expected results. Descriptions of some of the factors that could cause actual results to differ materially from these forward-looking statements are discussed in more detail in our filings with the U.S. Securities and Exchange Commission (the “SEC“), including the Risk Factors section of the Company’s Annual Report on Form 10-K filed with the SEC on March 31, 2023. Furthermore, if the forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. The forward-looking statements in this press release represent our views as of the date of this press release. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this press release.

Media Relations: pr@sharecare.com

Investor Relations: investors@sharecare.com


FAQ

When will Sharecare (SHCR) report its Q4 and full year fiscal 2023 financial results?

Sharecare (SHCR) will report its Q4 and full year fiscal 2023 financial results on March 28, 2024, after the market closes.

What time will the conference call to review the financial results be held on March 28, 2024?

The conference call to review the financial results will be held at 4:30 p.m. EDT on March 28, 2024.

How can U.S. participants access the conference call?

U.S. participants can access the conference call by dialing (833) 636-1352 and asking to be joined into the Sharecare call.

Where can the webcast replay of the call be accessed?

The webcast replay of the call can be accessed online at https://investors.sharecare.com and will remain available for approximately 90 days.

Sharecare, Inc.

NASDAQ:SHCR

SHCR Rankings

SHCR Latest News

SHCR Stock Data

531.78M
310.31M
6.29%
45.83%
0.98%
Health Information Services
Services-health Services
Link
United States of America
ATLANTA